FDA Inspection 1283432 — Tae Min Kim, M.D., Ph.D.
The FDA completed an inspection of Tae Min Kim, M.D., Ph.D. on Aug 29, 2025 in Seoul. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 29, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Seoul (Korea (the Republic of))
Additional Details
Clinical Investigator (CI)